Douglas Marvel
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Immune cells in cancer 2
- Inflammation biomarkers and pathways 1
-
- vaccines and immunoinformatics approaches 2
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Dmitry I. Gabrilovich (2 shared papers)Olivera J. Finn (3 shared papers)Adam M. Farkas (1 shared paper)Erica R. Thaler (1 shared paper)Alexander G. Chiu (1 shared paper)Benjamin S. Bleier (1 shared paper)Duane A. Sewell (1 shared paper)Kathleen T. Montone (1 shared paper)
- Journals
- The Journal of Immunology (2 papers)Journal of Clinical Investigation (1 paper)Frontiers in Immunology (1 paper)Cancer Research (1 paper)Archives of Otolaryngology - Head and Neck Surgery (1 paper)
- Partner nations
- United States
In The Last Decade
Douglas Marvel
6 papers receiving 829 citations
Douglas Marvel's Hit Papers
Peers
Comparison fields: 5 of 66
- Immunology 660
- Oncology 412
- Neurology 39
- Biological Psychiatry 11
- Cancer Research 65
Countries citing papers authored by Douglas Marvel
This map shows the geographic impact of Douglas Marvel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Marvel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Marvel more than expected).
Fields of papers citing papers by Douglas Marvel
This network shows the impact of papers produced by Douglas Marvel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Marvel. The network helps show where Douglas Marvel may publish in the future.
Co-authors
The 8 scholars most cited alongside Douglas Marvel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Hit paper breakdown → | 2015 | 822 |
| 2 | 2014 | 5 | |
| 3 | 2013 | 5 | |
| 4 | 2008 | 2 | |
| 5 | 2015 | 1 | |
| 6 | 2013 | 1 |
About Douglas Marvel
Douglas Marvel is a scholar working on Immunology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Oncology, having authored 6 papers that have together received 836 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers), T-cell and B-cell Immunology (2 papers), Immune cells in cancer (2 papers), Chemokine receptors and signaling (1 paper), Nanoplatforms for cancer theranostics (1 paper), Inflammation biomarkers and pathways (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (660 citations), Oncology (412 citations), Neurology (39 citations), Biological Psychiatry (11 citations) and Cancer Research (65 citations). Douglas Marvel has collaborated with scholars based in United States. Frequent co-authors include Dmitry I. Gabrilovich, Olivera J. Finn, Adam M. Farkas, Erica R. Thaler, Alexander G. Chiu, Benjamin S. Bleier, Duane A. Sewell and Kathleen T. Montone. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Investigation, Frontiers in Immunology, Cancer Research and Archives of Otolaryngology - Head and Neck Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.